AI-generated summary
The authors studied 808 nm near-infrared photobiomodulation in mice with paclitaxel-induced neuropathy and in cultured nerve and astrocyte cells. They report that three weeks of treatment reduced sensitivity symptoms, preserved nerve fiber density and mitochondrial structure, and lowered oxidative stress and cell death in the lab models. Findings come from animal and cell experiments and do not establish clinical benefit.
- Who or what was studied
- Mice with paclitaxel-induced chemotherapy-induced peripheral neuropathy, plus N2a neuroblastoma cells and normal human astrocytes in vitro
- Wavelengths
- 808 nm
- Limits stated in the abstract
- The study used animal and in vitro models only, so clinical efficacy in patients is not established.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 808 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Near-infrared, Neuropathy, Oxidative stress, Adenosine triphosphate, Neuroinflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.